Compare NBN & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBN | PACB |
|---|---|---|
| Founded | 1872 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 836.7M | 715.5M |
| IPO Year | N/A | 2010 |
| Metric | NBN | PACB |
|---|---|---|
| Price | $106.13 | $1.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $102.00 | $2.08 |
| AVG Volume (30 Days) | 95.9K | ★ 6.3M |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.04% | N/A |
| EPS Growth | ★ 38.19 | N/A |
| EPS | ★ 10.63 | N/A |
| Revenue | ★ $214,699,000.00 | $154,584,000.00 |
| Revenue This Year | $11.59 | $4.48 |
| Revenue Next Year | $11.26 | $11.99 |
| P/E Ratio | $9.97 | ★ N/A |
| Revenue Growth | ★ 36.17 | N/A |
| 52 Week Low | $78.17 | $0.85 |
| 52 Week High | $113.01 | $2.73 |
| Indicator | NBN | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 69.50 | 36.63 |
| Support Level | $98.15 | $1.77 |
| Resistance Level | $108.15 | $1.89 |
| Average True Range (ATR) | 3.08 | 0.13 |
| MACD | 0.63 | -0.06 |
| Stochastic Oscillator | 76.22 | 3.04 |
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.